New: Buy Now on Thomas and Pay Over Time with Credit Key   Learn More

InSightec

Software

INSIGHTEC Receives FDA Approval and CE Mark for Exablate Neuro with GE SIGNA Premier MR System

Haifa, Israel and Waukesha, Wisconsin, July 10, 2019 /PRNewswire/ -- GE Healthcare, a leader in medical technology and diagnostic and therapeutic imaging, and INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced FDA approval and CE mark for Exablate Neuro™ compatible with the SIGNA™Premier MRI system from GE Healthcare. The Exablate Neuro is a...

Read More »
Health, Medical, & Dental Supplies and Equipment

Non-Invasive Neurosurgery System leverages MR-focused ultrasound.

ExAblate Neuro employs imaging coil that improves intra-operative imaging performance on 1.5T MRI to allow precise surgery. Half-immersed in water bath that surrounds patients' heads during treatment, head coil- is invisible to ultrasonic acoustic beams that perform surgery. Resulting image resolution and clarity allows surgeons to make 1 mm adjustments during surgery.

Read More »
Health, Medical, & Dental Supplies and Equipment

InSightec Invites RSNA 2014 Attendees to Learn about Its MR-Guided Focused Ultrasound Solution for Treatment of Uterine Fibroids and Alleviation of Pain Caused by Bone Metastases

RSNA 2014: Radiological Society of North America Annual Meeting - McCormick Place, Chicago USA, November 30 - December 5th HAIFA, Israel – InSightec, world leader in MR-guided Focused Ultrasound (MRgFUS) will be on site at the RSNA 100th annual meeting to present its MR-guided Focused Ultrasound solution for ablation of uterine fibroids and alleviation of pain caused by bone metastases....

Read More »
Health, Medical, & Dental Supplies and Equipment

InSightec's ExAblate® 2000 Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) System is Approved for Sale in Canada

MRgFUS Offers Women the Only Non-Invasive Treatment for Symptomatic Uterine Fibroids HAIFA, Israel, March 12 - InSightec Ltd. announced today that Canada's healthcare regulatory body, Health Canada, has granted regulatory approval to the company's ExAblate-® 2000 Magnetic Resonance-guided Focused Ultrasound (MRgFUS) incisionless surgery system for the treatment of symptomatic uterine fibroids....

Read More »
Health, Medical, & Dental Supplies and Equipment

FDA Approves New Version of InSightec's ExAblate® 2000 that Speeds up Treatment Time

More Women now Eligible for the Only Incisionless Treatment Option for Symptomatic Uterine Fibroids HAIFA, Israel, March 1 // -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved software that significantly speeds up the treatment time of the company's ExAblate(R) 2000 Magnetic Resonance guided Focused Ultrasound (MRgFUS) system, while ensuring the...

Read More »
Health, Medical, & Dental Supplies and Equipment

FDA Approves Use of InSightec's ExAblate® 2000 with GE Healthcare's 3 Tesla Magnetic Resonance Imaging System

Non-invasive Magnetic Resonance-guided Focused Ultrasound Uterine Fibroid Treatment Now Compatible With Both 1.5 Tesla and 3 Tesla Systems HAIFA, Israel, March 1 // -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved use of the company's ExAblate(R) 2000 incisionless surgery system for uterine fibroids with GE Healthcare's 3 Tesla Magnetic Resonance...

Read More »
Software

INSIGHTEC Receives FDA Approval and CE Mark for Exablate Neuro with GE SIGNA Premier MR System

Haifa, Israel and Waukesha, Wisconsin, July 10, 2019 /PRNewswire/ -- GE Healthcare, a leader in medical technology and diagnostic and therapeutic imaging, and INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced FDA approval and CE mark for Exablate Neuro™ compatible with the SIGNA™Premier MRI system from GE Healthcare. The Exablate Neuro is a...

Read More »
Health, Medical, & Dental Supplies and Equipment

Non-Invasive Neurosurgery System leverages MR-focused ultrasound.

ExAblate Neuro employs imaging coil that improves intra-operative imaging performance on 1.5T MRI to allow precise surgery. Half-immersed in water bath that surrounds patients' heads during treatment, head coil- is invisible to ultrasonic acoustic beams that perform surgery. Resulting image resolution and clarity allows surgeons to make 1 mm adjustments during surgery.

Read More »
Health, Medical, & Dental Supplies and Equipment

InSightec Invites RSNA 2014 Attendees to Learn about Its MR-Guided Focused Ultrasound Solution for Treatment of Uterine Fibroids and Alleviation of Pain Caused by Bone Metastases

RSNA 2014: Radiological Society of North America Annual Meeting - McCormick Place, Chicago USA, November 30 - December 5th HAIFA, Israel – InSightec, world leader in MR-guided Focused Ultrasound (MRgFUS) will be on site at the RSNA 100th annual meeting to present its MR-guided Focused Ultrasound solution for ablation of uterine fibroids and alleviation of pain caused by bone metastases....

Read More »
Health, Medical, & Dental Supplies and Equipment

InSightec's ExAblate® 2000 Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) System is Approved for Sale in Canada

MRgFUS Offers Women the Only Non-Invasive Treatment for Symptomatic Uterine Fibroids HAIFA, Israel, March 12 - InSightec Ltd. announced today that Canada's healthcare regulatory body, Health Canada, has granted regulatory approval to the company's ExAblate-® 2000 Magnetic Resonance-guided Focused Ultrasound (MRgFUS) incisionless surgery system for the treatment of symptomatic uterine fibroids....

Read More »
Health, Medical, & Dental Supplies and Equipment

FDA Approves Use of InSightec's ExAblate® 2000 with GE Healthcare's 3 Tesla Magnetic Resonance Imaging System

Non-invasive Magnetic Resonance-guided Focused Ultrasound Uterine Fibroid Treatment Now Compatible With Both 1.5 Tesla and 3 Tesla Systems HAIFA, Israel, March 1 // -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved use of the company's ExAblate(R) 2000 incisionless surgery system for uterine fibroids with GE Healthcare's 3 Tesla Magnetic Resonance...

Read More »
Health, Medical, & Dental Supplies and Equipment

FDA Approves New Version of InSightec's ExAblate® 2000 that Speeds up Treatment Time

More Women now Eligible for the Only Incisionless Treatment Option for Symptomatic Uterine Fibroids HAIFA, Israel, March 1 // -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved software that significantly speeds up the treatment time of the company's ExAblate(R) 2000 Magnetic Resonance guided Focused Ultrasound (MRgFUS) system, while ensuring the...

Read More »

All Topics